Literature DB >> 20463076

Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

T Hoenen1, N Biedenkopf, F Zielecki, S Jung, A Groseth, H Feldmann, S Becker.   

Abstract

The morphogenesis and budding of virus particles represent an important stage in the life cycle of viruses. For Ebola virus, this process is driven by its major matrix protein, VP40. Like the matrix proteins of many other nonsegmented, negative-strand RNA viruses, VP40 has been demonstrated to oligomerize and to occur in at least two distinct oligomeric states: hexamers and octamers, which are composed of antiparallel dimers. While it has been shown that VP40 oligomers are essential for the viral life cycle, their function is completely unknown. Here we have identified two amino acids essential for oligomerization of VP40, the mutation of which blocked virus-like particle production. Consistent with this observation, oligomerization-deficient VP40 also showed impaired intracellular transport to budding sites and reduced binding to cellular membranes. However, other biological functions, such as the interaction of VP40 with the nucleoprotein, NP, remained undisturbed. Furthermore, both wild-type VP40 and oligomerization-deficient VP40 were found to negatively regulate viral genome replication, a novel function of VP40, which we have recently reported. Interestingly, while wild-type VP40 was also able to negatively regulate viral genome transcription, oligomerization-deficient VP40 was no longer able to fulfill this function, indicating that regulation of viral replication and transcription by VP40 are mechanistically distinct processes. These data indicate that VP40 oligomerization not only is a prerequisite for intracellular transport of VP40 and efficient membrane binding, and as a consequence virion morphogenesis, but also plays a critical role in the regulation of viral transcription by VP40.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20463076      PMCID: PMC2898221          DOI: 10.1128/JVI.00737-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

Authors:  H Feldmann; V E Volchkov; V A Volchkova; H D Klenk
Journal:  Arch Virol Suppl       Date:  1999

Review 2.  Rhabdovirus assembly and budding.

Authors:  Himangi R Jayakar; E Jeetendra; Michael A Whitt
Journal:  Virus Res       Date:  2004-12       Impact factor: 3.303

Review 3.  Molecular mechanism of paramyxovirus budding.

Authors:  Toru Takimoto; Allen Portner
Journal:  Virus Res       Date:  2004-12       Impact factor: 3.303

4.  Interactions of Marburg virus nucleocapsid proteins.

Authors:  S Becker; C Rinne; U Hofsäss; H D Klenk; E Mühlberger
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

5.  SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling.

Authors:  N Guex; M C Peitsch
Journal:  Electrophoresis       Date:  1997-12       Impact factor: 3.535

6.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

7.  VP40 octamers are essential for Ebola virus replication.

Authors:  Thomas Hoenen; Viktor Volchkov; Larissa Kolesnikova; Eva Mittler; Joanna Timmins; Michelle Ottmann; Olivier Reynard; Stephan Becker; Winfried Weissenhorn
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 8.  Filovirus budding.

Authors:  Luke D Jasenosky; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2004-12       Impact factor: 3.303

9.  Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.

Authors:  E Mühlberger; M Weik; V E Volchkov; H D Klenk; S Becker
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Ebola virus infection inversely correlates with the overall expression levels of promyelocytic leukaemia (PML) protein in cultured cells.

Authors:  Asa Szekely Björndal; Laszlo Szekely; Fredrik Elgh
Journal:  BMC Microbiol       Date:  2003-04-04       Impact factor: 3.605

View more
  62 in total

1.  Molecular determinants of arenavirus Z protein homo-oligomerization and L polymerase binding.

Authors:  Maria Eugenia Loureiro; Maximiliano Wilda; Jesica M Levingston Macleod; Alejandra D'Antuono; Sabrina Foscaldi; Cristina Marino Buslje; Nora Lopez
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection.

Authors:  Aaron E Lin; Todd M Greco; Katinka Döhner; Beate Sodeik; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2013-08-12       Impact factor: 5.911

3.  Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex.

Authors:  Gabriella Kiss; Jens M Holl; Grant M Williams; Eric Alonas; Daryll Vanover; Aaron W Lifland; Manasa Gudheti; Ricardo C Guerrero-Ferreira; Vinod Nair; Hong Yi; Barney S Graham; Philip J Santangelo; Elizabeth R Wright
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Inclusion bodies are a site of ebolavirus replication.

Authors:  Thomas Hoenen; Reed S Shabman; Allison Groseth; Astrid Herwig; Michaela Weber; Gordian Schudt; Olga Dolnik; Christopher F Basler; Stephan Becker; Heinz Feldmann
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

5.  Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication.

Authors:  Nadine Biedenkopf; Bettina Hartlieb; Thomas Hoenen; Stephan Becker
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

6.  Identification of amino acids in Marburg virus VP40 that are important for virus-like particle budding.

Authors:  Akiko Makino; Seiya Yamayoshi; Kyoko Shinya; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

Review 7.  Advances in virus-like particle vaccines for filoviruses.

Authors:  Kelly L Warfield; M Javad Aman
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

8.  Could the Ebola virus matrix protein VP40 be a drug target?

Authors:  Robert V Stahelin
Journal:  Expert Opin Ther Targets       Date:  2013-11-28       Impact factor: 6.902

Review 9.  Molecular mechanisms driving respiratory syncytial virus assembly.

Authors:  Fyza Y Shaikh; James E Crowe
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

10.  A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Authors:  Ari Watt; Felicien Moukambi; Logan Banadyga; Allison Groseth; Julie Callison; Astrid Herwig; Hideki Ebihara; Heinz Feldmann; Thomas Hoenen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.